CNPFX
Price
$70.11
Change
+$0.04 (+0.06%)
Updated
Aug 15 closing price
Net Assets
158.96B
GLVCX
Price
$74.45
Change
+$0.15 (+0.20%)
Updated
Aug 15 closing price
Net Assets
583.91M
Interact to see
Advertisement

CNPFX vs GLVCX

Header iconCNPFX vs GLVCX Comparison
Open Charts CNPFX vs GLVCXBanner chart's image
American Funds New Perspective 529F
Price$70.11
Change+$0.04 (+0.06%)
VolumeN/A
Net Assets158.96B
Invesco Global Focus C
Price$74.45
Change+$0.15 (+0.20%)
VolumeN/A
Net Assets583.91M
CNPFX vs GLVCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CNPFX vs. GLVCX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPFX is a Buy and GLVCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPFX has more cash in the bank: 159B vs. GLVCX (584M). CNPFX pays higher dividends than GLVCX: CNPFX (0.65) vs GLVCX (0.00). CNPFX was incepted earlier than GLVCX: CNPFX (23 years) vs GLVCX (18 years). GLVCX (1.98) is less costly to investors than CNPFX (0.84). CNPFX is a more actively managed with annual turnover of: 24.00 vs. GLVCX (13.00). CNPFX has a lower initial minimum investment than GLVCX: CNPFX (250) vs GLVCX (1000). GLVCX (14.27) and CNPFX (13.73) have marching annual gain over last year. CNPFX return over 5 years is better than : 40.18 vs. GLVCX (19.16).
CNPFXGLVCXCNPFX / GLVCX
Total Expense Ratio0.841.9842%
Annual Report Gross Expense Ratio0.841.9842%
Fund Existence23 years18 years-
Gain YTD15.5029.517163%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets159B584M27,226%
Annual Yield % from dividends0.650.00-
Returns for 1 year13.7314.2796%
Returns for 3 years35.9250.7771%
Returns for 5 years40.1819.16210%
Returns for 10 years98.9784.83117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETON17.040.34
+2.04%
Eton Pharmaceuticals
EHC120.381.25
+1.05%
Encompass Health Corp
WLYB39.94N/A
N/A
John Wiley & Sons
EXOZ9.70-0.29
-2.90%
eXoZymes Inc
AGMH2.21-0.09
-3.91%
AGM Group Holdings Inc